Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-13
2007-02-13
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S263200
Reexamination Certificate
active
10521715
ABSTRACT:
This invention relates to crystal form II of 2-[2-(1-chlorocyclopropyl)-3-(2-chloropenyl)-2-hydroxypropyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione of the formulato a process for its preparation and to its use for controlling unwanted microorganisms.
REFERENCES:
patent: 5789430 (1998-08-01), Jautelat et al.
patent: 96/16048 (1996-05-01), None
Angew. Chem. Int. Ed. 38, (month unavailable) 1999, pp. 3440-3461, Joel Bernstein et al, “Concomitant Polymorphs”.
J. Pharm. Sci., vol. 58, Aug. 1969, pp. 911-929, John Haleblian et al, “Pharmaceutical Applications of Polymorphism”.
Hasenack Karin
Olenik Britta
Seidel Erika
Vermeer Ronald
Bayer Cropscience AG
Henderson Richard E. L.
Saeed Kamal A.
LandOfFree
Crystal modification II of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal modification II of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal modification II of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3822164